Lv0
0 积分 2026-08-24 加入
Omalizumab for Chronic Idiopathic Urticaria: Potential to Taper Dose and Frequency?: 150
1天前
已完结
Efficacy of omalizumab 150 mg/month as a maintenance dose in patients with severe chronic spontaneous urticaria showing a prompt and complete response to the drug
1天前
已完结
Review for "Relapse rates and associated risk factors following omalizumab treatment in adolescents with chronic spontaneous urticaria"
1天前
已关闭
Impact of Omalizumab Treatment Withdrawal After 24 and 48 Weeks in Patients with Chronic Idiopathic Urticaria: Results From the XTEND-CIU Study
1天前
已完结
Chronic spontaneous urticaria treated with omalizumab (Xolair): A proposal of standardized tapering protocol before withdrawal to achieve the minimal effective dosage
1天前
已完结
Maintenance of Remission With Low-Dose Omalizumab in Long-Lasting, Refractory Chronic Urticaria
1天前
已完结
Retreatment With Omalizumab Results in Rapid Remission in Chronic Spontaneous and Inducible Urticaria
1天前
已完结
Improvement in quality of life impairment followed by relapse with 6-monthly periodic administration of omalizumab for severe treatment-refractory chronic urticaria and urticarial vasculitis
1天前
已完结
皖公网安备34019202002308
